Based on the study by Prat et al [15]which found that a PR cut point of ≥20% corresponds more closely to the luminal A subtype of breast cancer, our cohort has 105 tumours with a ER+HER2-PR≥20% (Luminal A) phenotype. This evidence concerns the gene ESR1 and neoplasm.